Statistics in Medicine · 1989 · 243 citations · 11 references
Public HealthBiostatisticsCardiologyClinical Data ManagementOutcomes ResearchSurvival AnalysisCardiovascular DiseaseClinical TrialsMissing Data ComputationMissing Data HandlingMissing Data ImputationMissing Data MethodsClinical Endpoints CorrelationClinical Outcome MeasurementHandling Missing Clinical DataInformative CensoringMissing Data Risk ManagementPenaltiesSample Size CalculationSurrogate Endpoints
A surrogate endpoint in a cardiovascular clinical trial is defined as endpoint measured in lieu of some other so-called 'true' endpoint. A surrogate is especially useful if it is easily measured and highly correlated with the true endpoint. Often the 'true' endpoint is one with clinical importance to the patient, for example, mortality or a major clinical outcome, while a surrogate is one biologically closer to the process of disease, for example, ejection fraction. Use of the surrogate can often lead to dramatic reductions in sample size and much shorter studies than use of the true endpoint. We discuss several problems common in trials with surrogate endpoints. Most important is the effect of missing data, especially in the face of informative censoring. Possible solutions are the assignment of scores or formal penalties to missing data.
11
Statistical Analysis with Missing Data
Roderick J. A. Little, Donald B. Rubin · Population · 1988 · 2.1K citations
Risk Stratification and Survival after Myocardial Infarction
New England Journal of Medicine · 1983 · 1.6K citations
Affectional Response in the Infant Monkey
Harry F. Harlow, Robert R. Zimmermann · Science · 1959 · 954 citations